APA

Winkler B., Baier K., Wagner S., Repa A., Eichler H. G., Scheiner O., Kraft D. & Wiedermann U. (20020819). Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Chicago

Winkler B, Baier K, Wagner S, Repa A, Eichler H G, Scheiner O, Kraft D and Wiedermann U. 20020819. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Harvard

Winkler B., Baier K., Wagner S., Repa A., Eichler H. G., Scheiner O., Kraft D. and Wiedermann U. (20020819). Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

MLA

Winkler B, Baier K, Wagner S, Repa A, Eichler H G, Scheiner O, Kraft D and Wiedermann U. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. : Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 20020819.